These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12438536)

  • 21. Inhibitory effects of the 5-HT(1A) receptor agonist buspirone on stress-induced hyperglycemia in mice: involvement of insulin and a buspirone metabolite, 1-(2-pyrimidinyl)piperazine (1-PP).
    Sugimoto Y; Takashima N; Noma T; Yamada J
    Biol Pharm Bull; 2005 Apr; 28(4):733-5. PubMed ID: 15802819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The azapirone metabolite 1-(2-pyrimidinyl)piperazine depresses excitatory synaptic transmission in the hippocampus of the alert rat via 5-HT1A receptors.
    Manahan-Vaughan D; Anwyl R; Rowan MJ
    Eur J Pharmacol; 1995 Dec; 294(2-3):617-24. PubMed ID: 8750726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of buspirone and 1-(2-pyrimidinyl)-piperazine (1-PP) in human plasma by capillary gas chromatography.
    Kivistö KT; Laitila J; Mårtensson K; Neuvonen PJ
    Ther Drug Monit; 1999 Jun; 21(3):317-21. PubMed ID: 10365644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroactive steroids differ in potency but not in intrinsic efficacy at the GABA(A) receptor in vivo.
    Visser SA; Gladdines WW; van der Graaf PH; Peletier LA; Danhof M
    J Pharmacol Exp Ther; 2002 Nov; 303(2):616-26. PubMed ID: 12388643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of buspirone as determined by ex vivo (3H)-DPAT binding.
    Sethy VH; Francis JW
    Life Sci; 1988; 42(10):1045-8. PubMed ID: 2964551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-hydroxytryptamine 1A receptor activation protects against N-methyl-D-aspartate-induced apoptotic cell death in striatal and mesencephalic cultures.
    Madhavan L; Freed WJ; Anantharam V; Kanthasamy AG
    J Pharmacol Exp Ther; 2003 Mar; 304(3):913-23. PubMed ID: 12604665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic-pharmacodynamic modeling of the respiratory depressant effect of norbuprenorphine in rats.
    Yassen A; Kan J; Olofsen E; Suidgeest E; Dahan A; Danhof M
    J Pharmacol Exp Ther; 2007 May; 321(2):598-607. PubMed ID: 17283225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of buprenorphine and fentanyl in rats: role of receptor equilibration kinetics.
    Yassen A; Olofsen E; Dahan A; Danhof M
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1136-49. PubMed ID: 15701707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential vascular alpha1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat.
    Centurión D; Mehotra S; Sánchez-López A; Gupta S; MaassenVanDenBrink A; Villalón CM
    Eur J Pharmacol; 2006 Mar; 535(1-3):234-42. PubMed ID: 16545797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 1-(2-pyrimidinyl)-piperazine, a buspirone metabolite, modulates bladder function in the anesthetized rat.
    Myers RA; Plym MJ; Signor LJ; Lodge NJ
    Neurourol Urodyn; 2004; 23(7):709-15. PubMed ID: 15382198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Buspirone transdermal administration for menopausal syndromes, in vitro and in animal model studies.
    Shumilov M; Touitou E
    Int J Pharm; 2010 Mar; 387(1-2):26-33. PubMed ID: 19961912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative behavioural profiles of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine (1-PP) in the murine elevated plus-maze.
    Cao BJ; Rodgers RJ
    Neuropharmacology; 1997 Aug; 36(8):1089-97. PubMed ID: 9294974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of buspirone and buspirone-like 1-A-agonists of serotonin on the level of systemic blood pressure].
    Komissarov IV; Mamonov AV; Filippov IT
    Biull Eksp Biol Med; 1991 Jul; 112(7):62-4. PubMed ID: 1686564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of the novel anxiolytic drug deramciclane on the pharmacokinetics and pharmacodynamics of the CYP3A4 probe drug buspirone.
    Laine K; Ahokoski O; Huupponen R; Hänninen J; Palovaara S; Ruuskanen J; Björklund H; Anttila M; Rouru J
    Eur J Clin Pharmacol; 2003 Dec; 59(10):761-6. PubMed ID: 14566442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Population pharmacokinetic-pharmacodynamic modelling of S 15535, a 5-HT(1A) receptor agonist, using a behavioural model in rats.
    Vis P; Della Pasqua O; Kruk M; Martin D; Mocaër E; Danhof M; Jochemsen R
    Eur J Pharmacol; 2001 Mar; 414(2-3):233-43. PubMed ID: 11239924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antagonism of clonidine antinociception by buspirone and 1-(2-pyrimidinyl)-piperazine.
    Cao BJ; Li WP
    Eur J Pharmacol; 1994 Jun; 259(1):75-8. PubMed ID: 7957598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticonflict effect of ipsapirone, buspirone and gepirone is not mediated by their common metabolite 1-(2-pyrimidinyl)piperazine.
    Przegalinski E; Tatarczynska E; Chojnacka-Wójcik E
    J Psychopharmacol; 1989 Jan; 3(3):180-5. PubMed ID: 22282903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the alpha 2-adrenoceptor blocking properties of buspirone and ipsapirone in healthy subjects. Relationship with the plasma concentration of the common metabolite 1-(2-pyrimidinyl)-piperazine.
    Berlin I; Chalon S; Payan C; Schöllnhammer G; Cesselin F; Varoquaux O; Puech AJ
    Br J Clin Pharmacol; 1995 Mar; 39(3):243-9. PubMed ID: 7619663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrinsic activity and comparative molecular dynamics of buspirone analogues at the 5-HT(1A) receptors.
    Strzelczyk AA; Jarończyk M; Chilmonczyk Z; Mazurek AP; Chojnacka-Wójcik E; Sylte I
    Biochem Pharmacol; 2004 Jun; 67(12):2219-30. PubMed ID: 15163553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Buspirone and 1-(2-pyrimidinyl)-piperazine attenuate xylazine-induced antinociception in the mouse.
    Cao BJ; Li WP
    J Pharm Pharmacol; 1994 Nov; 46(11):931-2. PubMed ID: 7897604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.